Acadia Pharmaceuticals is acquiring further rights to Neuren Pharmaceuticals’ newly approved Rett syndrome treatment for $100 million amid a better-than-expected launch of the drug. The
Eli Lilly will pay up to $1.925 billion in cash for weight loss drugmaker Versanis, marking the Big Pharma’s fourth acquisition this summer after deals
Just a few days after pricing a $150 million public offering, Iovance has now closed with 15% more raised, thanks to underwriters pitching in. Iovance
Caribou Biosciences shared an early cut of data Thursday afternoon that suggests its off-the shelf CAR-T therapy for patients with B cell lymphoma could rival
Roivant is in discussions with Roche to sell its experimental ulcerative colitis drug for several billion dollars, less than a year after acquiring the program
Theseus Pharmaceuticals has run into dose-limiting toxicities that’s forcing the company to abandon its KIT inhibitor, two months after presenting initial data on the program
→ After entering the public consciousness with the White House Coronavirus Task Force and embarking on a subsequent book tour, Deborah Birx has replaced Brian
Despite a promising launch, Threads — the social media app that hopes to unseat Twitter as a dominant space for online medical networking and communication
Twice-weekly subcutaneous ketamine helped alleviate symptoms of treatment-resistant depression, according to the phase III KADS study. Among those who received at least one flexible treatment
Superagers — people in their 80s who have the memory function of people 30 years younger — had specific characteristics that set them apart, an